APG Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $102M | Buy |
234,624
+43,239
| +23% | +$19.2M | 0.25% | 81 |
|
|
2026
Q1 | $74.2M | Buy |
191,385
+3,000
| +2% | +$1.4M | 0.24% | 82 |
|
|
2025
Q4 | $72.7M | Sell |
188,385
-12,203
| -6% | -$5.26M | 0.21% | 89 |
|
|
2025
Q3 | $66.9M | Sell |
200,588
-1,364
| -0.7% | -$570K | 0.19% | 100 |
|
|
2025
Q2 | $76.6M | Sell |
201,952
-124,776
| -38% | -$57.5M | 0.23% | 81 |
|
|
2025
Q1 | $147M | Sell |
326,728
-32,557
| -9% | -$15.2M | 0.45% | 47 |
|
|
2024
Q4 | $140M | Buy |
359,285
+235,265
| +190% | +$109M | 0.39% | 56 |
|
|
2024
Q3 | $51.7M | Sell |
124,020
-233,864
| -65% | -$112M | 0.34% | 47 |
|
|
2024
Q2 | $157M | Buy |
357,884
+50,190
| +16% | +$21.8M | 0.28% | 81 |
|
|
2024
Q1 | $119M | Sell |
307,694
-35,000
| -10% | -$14.8M | 0.21% | 115 |
|
|
2023
Q4 | $126M | Buy |
342,694
+42,398
| +14% | +$15.7M | 0.25% | 98 |
|
|
2023
Q3 | $104M | Sell |
300,296
-26,160
| -8% | -$9.15M | 0.21% | 113 |
|
|
2023
Q2 | $105M | Sell |
326,456
-26,152
| -7% | -$8.81M | 0.21% | 109 |
|
|
2023
Q1 | $102M | Sell |
352,608
-66,034
| -16% | -$19.8M | 0.22% | 116 |
|
|
2022
Q4 | $121M | Sell |
418,642
-102,647
| -20% | -$31.3M | 0.23% | 110 |
|
|
2022
Q3 | $154M | Sell |
521,289
-299,066
| -36% | -$86M | 0.4% | 59 |
|
|
2022
Q2 | $221M | Sell |
820,355
-336,534
| -29% | -$90.1M | 0.52% | 41 |
|
|
2022
Q1 | $271M | Sell |
1,156,889
-49,700
| -4% | -$11.8M | 0.51% | 45 |
|
|
2021
Q4 | $233M | Sell |
1,206,589
-22,100
| -2% | -$4.3M | 0.4% | 65 |
|
|
2021
Q3 | $192M | Sell |
1,228,689
-46,900
| -4% | -$9.16M | 0.34% | 78 |
|
|
2021
Q2 | $217M | Buy |
1,275,589
+28,250
| +2% | +$5.91M | 0.37% | 69 |
|
|
2021
Q1 | $228M | Sell |
1,247,339
-52,882
| -4% | -$11.6M | 0.39% | 62 |
|
|
2020
Q4 | $251M | Buy |
1,300,221
+655,929
| +102% | +$150M | 0.41% | 57 |
|
|
2020
Q3 | $150M | Buy |
644,292
+1,100
| +0.2% | +$303K | 0.26% | 99 |
|
|
2020
Q2 | $166M | Buy |
643,192
+457,871
| +247% | +$124M | 0.3% | 83 |
|
|
2020
Q1 | $44.1M | Buy |
185,321
+127,154
| +219% | +$29.2M | 0.09% | 240 |
|
|
2019
Q4 | $11.3M | Sell |
58,167
-19,279
| -25% | -$3.9M | 0.02% | 543 |
|
|
2019
Q3 | $12M | Sell |
77,446
-4,251
| -5% | -$752K | 0.02% | 524 |
|
|
2019
Q2 | $13.2M | Buy |
81,697
+21,500
| +36% | +$3.76M | 0.02% | 481 |
|
|
2019
Q1 | $9.86M | Hold |
60,197
| – | – | 0.02% | 503 |
|
|
2018
Q4 | $8.73M | Sell |
60,197
-4,600
| -7% | -$797K | 0.02% | 488 |
|
|
2018
Q3 | $10.8M | Sell |
64,797
-17,300
| -21% | -$3.08M | 0.02% | 486 |
|
|
2018
Q2 | $12M | Sell |
82,097
-12,600
| -13% | -$1.95M | 0.02% | 460 |
|
|
2018
Q1 | $12.5M | Sell |
94,697
-73,900
| -44% | -$12.1M | 0.02% | 436 |
|
|
2017
Q4 | $21M | Buy |
168,597
+90,529
| +116% | +$13.4M | 0.04% | 364 |
|
|
2017
Q3 | $11.9M | Buy |
78,068
+8,900
| +13% | +$1.34M | 0.02% | 489 |
|
|
2017
Q2 | $8.91M | Sell |
69,168
-107,296
| -61% | -$12.9M | 0.02% | 516 |
|
|
2017
Q1 | $19.3M | Sell |
176,464
-105,314
| -37% | -$9.27M | 0.04% | 422 |
|
|
2016
Q4 | $19.7M | Sell |
281,778
-32,800
| -10% | -$2.67M | 0.04% | 420 |
|
|
2016
Q3 | $27.4M | Buy |
314,578
+400
| +0.1% | +$37.8K | 0.05% | 386 |
|
|
2016
Q2 | $27M | Buy |
314,178
+37,600
| +14% | +$3.25M | 0.05% | 361 |
|
|
2016
Q1 | $22M | Sell |
276,578
-57,600
| -17% | -$5.21M | 0.05% | 381 |
|
|
2015
Q4 | $42M | Sell |
334,178
-43,790
| -12% | -$5.29M | 0.1% | 253 |
|
|
2015
Q3 | $39.4M | Sell |
377,968
-10,603
| -3% | -$1.36M | 0.09% | 264 |
|
|
2015
Q2 | $48M | Buy |
388,571
+104,907
| +37% | +$13.2M | 0.1% | 257 |
|
|
2015
Q1 | $33.5M | Sell |
283,664
-4,769
| -2% | -$571K | 0.07% | 316 |
|
|
2014
Q4 | $34.3M | Buy |
288,433
+26,534
| +10% | +$2.99M | 0.07% | 320 |
|
|
2014
Q3 | $29.4M | Sell |
261,899
-23,877
| -8% | -$2.27M | 0.06% | 318 |
|
|
2014
Q2 | $27.1M | Buy |
285,776
+44,313
| +18% | +$3.11M | 0.06% | 329 |
|
|
2014
Q1 | $17.1M | Buy |
241,463
+23,914
| +11% | +$1.89M | 0.04% | 378 |
|
|
2013
Q4 | $16.2M | Sell |
217,549
-11,537
| -5% | -$803K | 0.05% | 365 |
|
|
2013
Q3 | $17.4M | Sell |
229,086
-41,349
| -15% | -$3.29M | 0.05% | 351 |
|
|
2013
Q2 | $21.6M | Buy |
+270,435
| New | +$19.9M | 0.07% | 322 |
|
Other funds holding VRTX
VCM
VPM
APG Asset Management's VRTX Position: Q2 2026 in Review
APG Asset Management increased its Vertex Pharmaceuticals (VRTX) stake by 23% in Q2 2026, buying an estimated $19.2M and bringing the position to 234,624 shares worth $102M. The position accounts for 0.25% of the portfolio, ranked #81.
APG Asset Management first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $271M in Q1 2022. 1,436 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- APG Asset Management held 234,624 shares of Vertex Pharmaceuticals worth $102M as of Q2 2026.
- APG Asset Management bought 43,239 Vertex Pharmaceuticals shares in Q2 2026, an estimated $19.2M.
- Vertex Pharmaceuticals made up 0.25% of APG Asset Management's portfolio in Q2 2026, its #81 holding.
- APG Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- APG Asset Management's Vertex Pharmaceuticals position peaked at $271M in Q1 2022.
- 1,436 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on APG Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.